drug discovery - International Pharmaceutical Industry

News

Novartis and Ratio Enter Radiotherapeutics Partnership Worth $745m

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a somatostatin receptor 2 (SSTR2)-targeting ...

27 November 2024 News biotechnology | drug

Continue Reading →

News

Dotmatics and RockStep partner on digitalised in vivo drug discovery

Dotmatics Ltd, an Insightful Science company that provides scientific informatics software, has announced a partnership with RockStep, a developer of software tools ...

13 October 2021 News Dotmatics | drug discovery

Continue Reading →

News

Enamine expands collaboration with UCSF to explore synthetically feasible chemical space

Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, has today announced that it has expanded its collaborat...

25 January 2018 News compounds | drug discovery

Continue Reading →

News

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today...

16 January 2018 News antibody | drug discovery

Continue Reading →

News

Drug discovery must change to urgently address global health needs: Oxford researchers call for a new Pharmaceutical Commons

A new paper published today by the Oxford Martin School at the University of Oxford calls for ‘open science’ approaches to drug discovery and offers ways forward tha...

8 December 2017 News drug discovery | global health

Continue Reading →

News

Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation

Horizon Discovery, a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPR...

14 November 2017 News drug discovery | editing

Continue Reading →

Editorial Archive

Near-Infrared Fluorescent Methods for Protein Analysis

Pages from IPI-Volume4Issue3-4 Download

28 September 2012 Editorial Archive drug discovery | infrared

Continue Reading →

Drug Discovery, Development & Delivery v4i3

Straightforward or Challenging? Why It Matters Where You Place DM&PK Studies

Medical research has been a major underlying factor leading to the dramatic reduction in overall morbidity and mortality in the 20th century. In his book, The De...

28 September 2012 Drug Discovery, Development & Delivery v4i3 | Volume 4 Issue 3 DM&PK | drug discovery

Continue Reading →

Clinical Research v4i3

Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery

The success rate in predicting clinical efficacy of anti-cancer modalities using current xenograft models has been reported to be only 30-40%. Standard xenograft...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 clinical | drug discovery

Continue Reading →

How to choose the right vial: Influencing factors and solutions for liquid fills

Current Edition

Novartis and Ratio Enter Radiotherapeutics Partnership Worth $745m

Dotmatics and RockStep partner on digitalised in vivo drug discovery

Enamine expands collaboration with UCSF to explore synthetically feasible chemical space

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

Drug discovery must change to urgently address global health needs: Oxford researchers call for a new Pharmaceutical Commons

Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation

Near-Infrared Fluorescent Methods for Protein Analysis

Straightforward or Challenging? Why It Matters Where You Place DM&PK Studies

Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery

Reduce Costs and Gain Expertise by Outsourcing your Cell Culture and Cryostorage

International Pharmaceutical Industry